University of California, Los Angeles
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Los Angeles sits in the top decile of US sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count).
University of California, Los Angeles: 897 sponsored US clinical trials, 158 recruiting.
University of California, Los Angeles sponsors 897 registered US clinical trials on ClinicalTrials.gov, 158 of them currently recruiting, and 622 completed. 98 of these trials are in Phase 3-4 (later-stage) and 194 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.
Top-decile sponsor footprint
University of California, Los Angeles ranks in the top decile of sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
622 of 679 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
897 total, page 4 of 18
Regional Blocks for Lateral Condyle Fractures
NCT03796572
Supracondylar Post-Operative Pain Study
NCT03759028
HIFU for Focal Ablation of Prostate Tissue: An Observational Study
NCT03620786
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
NCT04937868
ASXL-Related Disorders Natural History Study
NCT03303716
Improving Bladder Function in SCI by Neuromodulation
NCT02331979
Recording of Intraoperative Spinal Cord Stimulation and Monitoring
NCT05356286
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
NCT00695214
An Evaluation of Epic EHR AI Outpatient Chart Summarization
NCT07438743
Effects of Magnesium L-Threonate on Sleep, Recovery, and Athletic Performance in Collegiate Athletes
NCT07015047
TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney Transplantation
NCT07287800
A Pilot rTMS Trial for Neuropsychiatric Symptoms of Long-COVID
NCT06586398
A Randomized Controlled Trial of Ambient Artificial Intelligence Scribe Technologies
NCT06792890
Intervention Trial for Healthcare Workers With Anxiety
NCT06460285
Multi-ethnic Multi-level Strategies and Behavioral Economics to Eliminate Hypertension Disparities in Los Angeles County
NCT06359691
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
NCT06526884
Mixed Methods Evaluation of the Pomona Household Universal Grant (HUG) Program
NCT06505811
Increasing the Feasibility, Impact, and Equity of the Medicare Annual Wellness Visit (AWV)
NCT05910736
Wishes to Improve Support and Humanity at End-of-life in Safety-net Hospitals
NCT06277310
PILOT Phase: BPD Study
NCT07223619
Skin Change Actions by Nursing
NCT06127524
Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo
NCT05949008
Remote Game-based Exercise Program for Cognitive and Motor Function Improvement
NCT05235113
Flashed Light Therapy for Adolescents With ADHD and Delayed Sleep Timing
NCT06036420
Immunological Tolerance in Patients With Mismatched Kidney Transplants
NCT05806749
AWV Practice Redesign Toolkit (Tailored Intervention)
NCT05563415
AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT)
NCT04859296
Non-invasive Brain Mapping of Movement Facilitation in Parkinson's Disease
NCT05179187
Inflammation in Methamphetamine and STIs (IMSTI)
NCT05162391
Angiotensin 2 for AKI After OLT
NCT04592744
Alcoholic Liver Disease and the Gut Microbiome
NCT05007470
Effect of Addition of Steroids on Duration of Analgesia
NCT04126824
Analgesic and Subjective Effects of Terpenes
NCT04451863
Magnetically Controlled Capsule Endoscopy Feasibility Study in Gastric Motility
NCT05004012
A Shared Decision Making Intervention for Diabetes Prevention in Women With a History of Gestational Diabetes Mellitus
NCT04897945
Open Trial of Biofeedback for Respiratory Symptoms
NCT05973513
mHealth to Enhance & Sustain Drug Use Reduction of the QUIT BI in Primary Care
NCT04935606
Boosting Language Outcomes of Minimally Verbal Children With ASD (BLOOM)
NCT04218331
PRISM Intervention Study
NCT03883139
Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial
NCT04338152
Firearm-Safety Counseling: Medical Student Training
NCT05242627
Stem Cell Therapy for Limbal Stem Cell Deficiency
NCT03957954
COVID-19 Recovered Volunteer Research Participant Pool Registry
NCT04359602
Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled Expansion Stents
NCT04315571
Financial Incentives for Smoking Treatment II
NCT03979885
acTBS Treatment for Inpatient Subjects With Suicidality
NCT04197765
Effectiveness of a CBT-based mHealth Intervention Targeting MOUD Retention, Adherence, and Opioid Use
NCT04808479
Envarsus XR® in Adolescent Renal Transplant Recipients
NCT03266393
Clinic-Based Financial Coaching and Family Health and Development
NCT03736590
Open Pilot Trial of BHV-4157
NCT03408080
What is open in the University of California, Los Angeles pipeline
158 recruiting of 897 indexed (18% open); 622 completed (69%).
Phase mix: 98 late (III/IV) vs 194 early (I/II) (early-phase heavy).
Top condition: Depression (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Los Angeles: open-pipeline peers nationwide
Peers matched on 897 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, Los Angeles sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 897 trials (± recruiting share)
- Indiana University · 890 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- ConvaTec · 18% recruiting · 17 trials
- Endologix · 18% recruiting · 17 trials
- National Institute on Deafness and Other Communication Disorders (NIDCD) · 18% recruiting · 34 trials
- NICHD Pelvic Floor Disorders Network · 18% recruiting · 17 trials
Related
What to do with this University of California, Los Angeles page
897 registered trials is a research-attention snapshot, not an endorsement of University of California, Los Angeles or any single study.
- 158 of University of California, Los Angeles's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of California, Los Angeles studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Los Angeles pipeline card: 897 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.